Bibliography

Export 273 results:
Filters: Keyword is Transplantation, Homologous  [Clear All Filters]
2003
Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion. 2003;43(8):1153-61.
Barahmani N, Whaley K, Duvic M. Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol. 2003;49(6):1192.
Clostridial endophthalmitis after cornea transplantation--Florida, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(48):1176-9.
Boone DW. Complications of iliac crest graft and bone grafting alternatives in foot and ankle surgery. Foot Ankle Clin. 2003;8(1):1-14.
Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation. 2003;76(5):871-3.
CDC. Invasive Streptococcus pyogenes after allograft implantation--Colorado, 2003.. Vol 52. United States; 2003. (MMWR MorbMortalWklyRep; vol 52; no 48).
for and(CDC) C. Invasive Streptococcus pyogenes after allograft implantation--Colorado, 2003. MMWR MorbMortalWklyRep. 2003;52(48):4.
Fabrega E, Garcia-Suarez C, Guerra A, Orive A, Casafont F, Crespo J, et al. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach. Liver Transpl. 2003;9(9):16.
Loren AW, Desai S, Gorman RC, Schuchter LM. Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation. 2003;76(4):741-3.
Au WY, Lam CC, Lie AK, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol. 2003;120(4):626-30.
2002
Gopcsa L, Barta A, Banyai A, Konya M, Pajor L, Foldi J, et al. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant. 2002;29(5):449-52.
McMilin KD. Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy. Transfusion. 2002;42(4):495-504.
James LA, Gower A. The clinical significance of femoral head culture results in donors after hip arthroplasty: a preliminary report. J Arthroplasty. 2002;17(3):355-8.
Botterel F, Ichai P, Feray C, Bouree P, Saliba F, Tur Raspa R, et al. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J Clin Microbiol. 2002;40(5):1648-50.
Au WY, Chan EC, Siu LL, Lau TC, Lie AK, Ma SK, et al. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol. 2002;119(3):777-80.
Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. 2002;29(12):999-1003.
Issa NC, Patel R. Potential for expansion of the donor pool using liver allografts from donors with bacterial meningitis. Liver Transpl. 2002;8(10):977-9.
Mehta JS, Franks WA. The sclera, the prion, and the ophthalmologist. Br J Ophthalmol. 2002;86(5):587-92.
Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2002;118(4):1112-9.
Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. ArchSurg. 2002;137(5):2.

Pages